Nippon Life India Asset Management Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
NAM-INDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nippon Life India Asset Management has filed a quarterly compliance report on the use of proceeds from its 2017 IPO. The company raised a total of Rs. 616.90 Crores (gross) and Rs. 588.85 Crores (net) in November 2017. As of June 30, 2025, Rs. 397.84 Crores has been deployed across the stated objects. The company confirms there is NIL deviation or variation from the original purposes stated in the prospectus. Full utilization has been completed for IT upgrade (Rs. 40.65 Cr), advertising/marketing (Rs. 72.09 Cr), lending to its AIF subsidiary (Rs. 125 Cr), investment in mutual fund schemes (Rs. 100 Cr), and general corporate purposes (Rs. 47.80 Cr). Only Rs. 12.30 Cr of the Rs. 38.31 Cr allocated for new branches has been spent, and the entire Rs. 165 Cr earmarked for inorganic growth remains unutilized.
This is a routine regulatory disclosure confirming that IPO funds have been used in line with originally stated purposes, with no misuse or deviation. It signals disciplined capital allocation and good governance, which is positive for investor confidence, though the untouched Rs. 165 Cr inorganic growth allocation suggests acquisition plans remain on hold.